Centrus Energy Corp. 10-Q Summary: Q3 2025
Business Context and Reporting Period
This summary covers the quarterly period ended September 30, 2025. Centrus Energy Corp. operates two primary segments: LEU (Low-Enriched Uranium), which supplies nuclear fuel components to commercial utilities, and Technical Solutions, which provides uranium enrichment and technical services, primarily to the U.S. Department of Energy (DOE) under the HALEU (High-Assay Low-Enriched Uranium) Operation Contract. The company is currently navigating geopolitical risks related to Russian uranium imports and executing a major expansion of its enrichment capacity in Piketon, Ohio.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Total Revenue | $74.9 million | $57.7 million | $302.5 million | $290.4 million |
| Gross Profit (Loss) | $(4.3) million | $8.9 million | $82.5 million | $49.7 million |
| Operating Income (Loss) | $(16.6) million | $(7.6) million | $37.4 million | $2.9 million |
| Net Income (Loss) | $3.9 million | $(5.0) million | $60.0 million | $19.5 million |
| Diluted EPS | $0.19 | $(0.30) | $3.16 | $1.20 |
| Cash & Equivalents | $1,631.8 million (as of Sept 30, 2025) | |||
| Long-Term Debt | $1,173.5 million (as of Sept 30, 2025) | |||
| Working Capital | $1,538.4 million (as of Sept 30, 2025) |
Material Changes vs. Prior Period
- Revenue Mix Shift: Q3 2025 revenue increased 30% year-over-year, driven by a $34.1 million uranium sale in the LEU segment. However, SWU revenue dropped 69% due to lower average pricing, resulting in a Q3 gross loss of $4.3 million compared to a profit of $8.9 million in Q3 2024.
- YTD Profitability Surge: For the nine months ended September 30, 2025, Net Income jumped 208% to $60.0 million. This was driven by a $32.8 million increase in gross profit, a $20.4 million increase in investment income (due to higher cash balances), and an $11.8 million gain from the extinguishment of 8.25% Notes.
- Debt Restructuring: The company redeemed all $74.3 million of its 8.25% Notes in March 2025. Conversely, it issued $402.5 million of 2.25% Convertible Notes in late 2024 and $805.0 million of 0% Convertible Notes in August 2025, significantly increasing long-term debt but bolstering liquidity.
- Investment Income: Investment income rose to $12.9 million in Q3 2025 (from $2.6 million in Q3 2024) due to interest earned on the substantial cash proceeds from recent debt and equity issuances.
Guidance, Outlook, and Risks
- HALEU Contract Progress: The DOE extended the Phase 2 period of the HALEU Operation Contract through October 31, 2025, due to supply chain delays with 5B Cylinders. The DOE exercised Option 1a of Phase 3, extending performance through June 30, 2026, with a funded value of $108.2 million.
- Expansion Plans: Centrus announced plans for a major expansion of uranium enrichment capacity in Piketon, Ohio, targeting both LEU and HALEU production. This requires multi-billion dollar investment and depends on federal funding and off-take commitments.
- Geopolitical Risks: The company faces significant risks from the U.S. Import Ban Act (banning Russian LEU) and the Russian Decree (restricting exports). While waivers were granted for 2024-2027 deliveries, future waivers are not guaranteed. The company relies heavily on the TENEX Supply Contract for over half of its expected LEU deliveries through 2027.
- Regulatory & Funding Risks: Executive Order 14154 paused certain federal funding distributions pending review, creating uncertainty for IRA-funded projects. Additionally, the company is subject to ongoing litigation regarding historical contamination at the Portsmouth GDP site, though it believes it is indemnified under the Price-Anderson Act.
Investor Verification Checklist
- Waiver Status: Verify the status of pending DOE waiver requests for Russian LEU imports for 2026 and 2027, as failure to secure these could disrupt supply chains.
- Convertible Note Conversion: Monitor the 2.25% Convertible Notes, which became convertible in Q3 and Q4 2025 due to stock price performance, and assess potential dilution or cash settlement impacts.
- DOE Funding Continuity: Confirm the impact of Executive Order 14154 on the $62.4 million Section 48C tax credit allocation and future task orders under HALEU/LEU production contracts.
- Inventory Valuation: Review the revaluation of inventory loans and the composition of the $416.3 million inventory balance, particularly given the volatility in SWU spot prices.
- Legal Contingencies: Assess the potential liability exposure from the Portsmouth GDP class action lawsuits, despite the company's reliance on Price-Anderson indemnification.